Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00313547Phase 4Terminated
Phase 4, randomised trial in hypertension (HTN) comparing Quinapril 40 mg with Quinapril 10 mg + Amlodipine 5 mg (2 arms). Primary endpoint: Heart rate variability at 24 hours. Started Apr 2006; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00313547.